Signalling by cytokines interacting with the interleukin-2 receptor γ chain

Cytokines, Cellular and Molecular Therapy

Volumn 4, Issue 4, 1998, Pages 243-256

  Demoulin, J B ^a,b   Renauld, J C ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

Author keywords

Common chain; JAK; Lymphocyte signalling; PI 3 kinase; STAT

Indexed keywords

INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 7; INTERLEUKIN 9; PROTEIN TYROSINE KINASE; STAT3 PROTEIN; STAT5 PROTEIN; TRANSCRIPTION FACTOR;

APOPTOSIS; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENE REARRANGEMENT; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL DIVISION; CYTOKINES; INTERLEUKIN-13; INTERLEUKIN-15; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-7; INTERLEUKIN-9; JANUS KINASE 3; MODELS, BIOLOGICAL; PROTEIN KINASE C; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, CYTOKINE; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES;

EID: 0031751202     PISSN: 13684736     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (133)

1. Takeshita T, Asao H, Ohtani K et al, Cloning of the γ chain of the human IL-2 receptor. Science (1992) 257: 379-82.
2. Noguchi M, Yi H, Rosenblatt H et al, Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans. Cell (1993) 73: 147-57.
3. Schorle II, Holtschke T, Hünig T et al, Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature (1991) 352: 621-4.
4. Kishimoto T, Taga T, Akira S, Cytokine signal transduction Cell (1994) 76: 253-62.
5. Russell SM, Keegan AD, Harada N et al, Interleukin-2 receptor γ chain: a functional component of the interleukin-4 receptor. Science (1993) 262: 1880-3.
6. Russell S, Johnston J, Noguchi M et al, Interaction of IL-2Rβ and γc chains with Jak1 and Jak3: implications for XSCID and XCID. Science (1993) 266: 1042-5.
7. Noguchi M, Nakamura Y, Russel SM et al, Interleukin-2 receptor γ chain: a functional component of the interleukin-7 receptor. Science (1993) 262: 1877-80.
8. Kondo M, Takeshita T, Ishii N et al, Sharing of the interleukin-2 (IL-2) receptor γ chain between receptors for IL-2 and IL-4. Science (1993) 262: 1874-7
9. Kondo M, Takeshita T, Higuchi M et al, Functional participation of the IL-2 receptor γ chain in IL-7 receptor complexes. Science (1994) 263: 1453-4.
10. Kimura Y, Takeshita T, Kondo M et al, Sharing of the IL-2 receptor γ chain with the functional IL-9 receptor complex. Int Immunol (1995) 7: 115-20.
11. Di Santo J, Kühn R, Müller W, Common cytokine receptor γ chain (γc)-dependent cytokines: understanding in vivo functions by gene targeting. Immunol Rev (1995) 148: 19-34.
12. Johnston J, Bacon C, Riedy M et al, Signaling by IL-2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency. J Leuk Biol (1996) 60: 441-52.
13. Duschl A, Sebald W, Transmembrane and intracellular signalling bv interleukin-4: receptor dimerization and beyond. Eur Cytokine Netw (1996) 7: 37-49.
14. Taniguchi T, Cytokine signaling through nonreceptor protein tyrosine kinases Science (1995) 268: 251-5.
15. Nicola N, Guidebook to Cytokines and their Receptors. Sambrook and Tooze/Oxford University Press, Oxford, 1994.
16. Murakami M, Narazaki M, Hibi M et al, Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family. Proc Natl Acad Sci USA (1991) 88: 11349-53.
17. Renauld JC, Druez C, Kermouri A et al, Expression cloning of the murine and human interleukin 9 receptor cDNAs. Proc Nad Acad Sci USA (1992) 89: 5690-4.
18. Gin J, Kumaki S, Ahdieh M et al, Identification and cloning of a novel IL-15 binding protein that is structurally related to the a chain of the IL-2 receptor. EMBO J (1995) 14: 3654-63.
19. Nelson B, Lord J, Greenberg P, Cytoplasmic domains of the interleukin-2 receptor β and γ chains mediate the signal for T-cell proliferation. Nature (1994) 369: 333-6.
20. Nakamura Y, Russell S, Mess S et al, Heterodimerizanon of the IL-2 receptor β- and γ chain cytoplasmic domains is required for signalling Nature (1994) 369: 330-3.
21. Giri J, Ahdieh M, Eisenman J et al, Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J (1994) 13: 2822-30.
22. Tagaya Y, Bamford R, DeFilippis A et al, IL-15: a pleiotropic cytokine with diverse receptor/signalling pathways whose expression is controlled at multiple levels. Immunity (1996) 4: 329-36.
23. Hilton DJ, Zhang JG, Metcalf D et al, Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc Natl Acad Sci USA (1996) 93: 497-501.
24. Gauchat J-F, Schlagenhauf E, Feng N-P et al, A novel 4-kb interleukin-13 receptor α mRNA expressed in human B, T, and endothelial cells encoding an alternate type-II interleukin-4/interleukin-13 receptor. Eur J Immunol (1997) 27: 971-8.
25. Zurawski G, de Wies J, Interleukin 13, an interleukin 4-like cytokine that act on monocytes and B cells, but not on T cells. Immunol Today (1994) 15: 19-26.
26. Hatakeyama M, Mori H, Doi T et al, A restricted cytoplasmic region of IL-2 receptor β chain is essential for growth signal transduction but not for ligand binding and internalization. Cell (1989) 59: 837-15.
27. Corcoran A, Smart F, Cowling R et al, The interleukin-7 receptor of chain transmits distinct signals for proliferation and differentiation during B lymphopoiesis. EMBO J (1996) 15: 1924-32.
28. Demoulin JB, Uyttenhove C, Van Roost E et al, A single tyrosine of the interleukin-9 (TL-9) receptor is required for STAT activation, antiapoptotic activity, and growth regulation by IL-9. Mol Cell Biol (1996) 16: 4710-16.
29. Keegan A, Nelms K, Wang LM et al, Interleukin 4 receptor: signaling mechanisms. Immunol Today (1994) 15: 423-32.
30. Ihle J, Kerr I, Jaks and Stats in signaling by the cytokine receptor superfamily. Trends Genet (1995) 11: 69-74.
31. Higuchi M, Asao H, Tanaka N et al, Dispensability of Jak1 tyrosine kinase for interleukin-2-induced cell growth signaling in a human T cell line. Eur J Immunol (1996) 26: 1322-7.
32. Pellegrini S, Dusanter-Fourt I, The structure, regulation and function of the Janus kinases QAKs) and the signal transducers and activators of transcription. Eur J Biochem (1997) 248: 615-33.
33. Malabarba M, Kirken R, Rui R et al, Activation of JAK3, but not JAK1, is critical to interleukin-4 (EL-4) stimulated proliferation and requires a membrane-proximal region of IL-4 receptor α. J Biol Chem (1995) 270: 9630-7.
34. Kirken R, Rui H, Malabarba G et al, Activation of JAK3, but not JAK1, is critical for IL-2-induced proliferation and Stat5 recruitment by a COOH-terminal region of the IL-2 receptor (β-chain. Cytokine (1995) 7: 689-700.
35. Oakes S, Candotti F, Johnston J et al, Signaling via IL-7 and IL-4 in JAK3-deficient severe combined immunodeficiency lymphocytes: JAK3-dependent and independent pathways. Immunity (1996) 5: 605-15.
36. Kawahara A, Minami Y, Miyazaki T et al, Critical role of the interleukin 2 (IL-2) receptor γ-chain-associated JAK3 in the IL-2-induced c-fos and c-myc, but not bcl-2, gene induction. Proc Natl Acad Sci USA (1995) 92: 8724-8.
37. Goldsmith MA, Lai SY, Xu W et al, Growth signal transduction by the human interleukin-2 receptor requires tyrosines of the β chain and non tyrosine residues of the γc chain. J Biol Chem (1995) 270: 21729-37.
38. Lai SY, Xu W, Gaffen SL et al, The molecular role of the common γc subunit in signal transduction reveals functional asymmetry within multimeric cytokine receptor complexes. Proc Natl Acad Sci USA (1996) 93: 231-5.
39. Lai SY, Xu W, Gaffen SL et al, The molecular role of the common γc in signal transduction reveals functional asymmetry within multimeric cytokine receptor complexes. Proc Natl Acad Sci USA (1996) 93: 231-5.
40. Welham M, Learmonth L, Bone H et al, Interleukin-13 signal transduction in lymphohemopoietic cells. J Biol Chem (1995) 270: 12286-96.
41. Taylor N, Candotti F, Smith S et al, Interleukin-4 signaling in B lymphocytes from patients with X-linked severe combined immunodeficiency. J Biol Chem (1997) 272: 7314-19.
42. Yin T, Yang L, Yang YC, Tyrosine phosphorylation and activation of JAK family tyrosine kinases by interleukin-9 in MO7E cells. Blood (1995) 85: 3101-6.
43. Takeshita T, Arita T, Higuchi M et al, STAM, signal transducing adaptor molecule, is associated with Janus kinases and involved in signaling for cell growth and c-myc induction. Immunity (1997) 6: 449-57.
44. Miyazaki T, Liu Z-J, Kawahara A et al, Three distinct IL-2 signalling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation. Cell (1995) 81: 223-31.
45. Minami Y, Nakagawa Y, Kawahara A et al, Protein tyrosine kinase Syk is associated with and activated by the IL-2 receptor: possible link with the c-myc induction pathway. Immunity (1995) 2: 89-100.
46. Hatakeyama M, Kono T, Kobayashi N et al, Interaction of the IL-2 receptor with the src-family kinase p561ck: identification of novel intermolecular association. Science (1991) 252: 1523-8.
47. Venkitaraman A, Cowling R, Interleukin 7 receptor functions by recruiting the tyrosine kinase p59fyn through a segment of its cytoplasmic tail. Proc Natl Acad Sci USA (1992) 89: 12083-7.
48. Minami Y, Kono T, Yamada K et al, Association of p561ck with IL-2 receptor β chain is critical for the IL-2-induced activation of p561ck. EMBO J (1993) 12: 759-68.
49. Izuhara K, Feldman R, Greer P et al, Interaction of the c-fes protooncogene product with the interleukin-4 receptor. J Biol Chem (1994) 269: 18623-9.
50. Izuhara K, Harada N, Interleukin-4 activates two distinct pathways of phosphatidylinositol-3 kinase in the same cells. Biochem Biophys Res Commun (1996) 13: 624-9.
51. Eck M, Dhe-Paganon S, Trüb T et al, Structure of the IRS-1 PTB domain bound to the juxtamembrane region of the insulin receptor. Cell (1996) 85: 695-705.
52. Sun X, Wang L-M, Zhang Y et al, Role of IRS-2 in insulin and cytokine signalling. Nature (1995) 377: 173-7.
53. Welham M, Bone H, Levings M et al, Insulin receptor substrate-2 is the major 170-kDa protein phosphorylated on tyrosine in response to cytokines in murine lymphohemopoietic cells. J Biol Chem (1996) 272: 1377-81.
54. Keegan AD, Nelms K, White M et al, An TJL-4 receptor region containing an insulin receptor motif is important for IL-4-mediated IRS-1 phosphorylation and cell growth. Cell (1994) 76: 811-20.
55. Burfoot MS, Rogers NC, Waiting D et al, Janus kinase-dependent activation of insulin receptor substrate 1 in response to interleukin-4, oncostatin M, and the interferons. J Biol Chem (1997) 272: 24183-90.
56. Pruett W, Yuan Y, Rose E et al, Association between GRB2/Sos and insulin receptor substrate 1 is not sufficient for activation of extracellular signal-regulated kinases by interleukin-4: implication for Ras activation by insulin. Mol Cell Biol (1995) 15: 1778-85.
57. Johnston J, Wang L-M, Hanson E et al, Interleukins 2, 4, 7 and 15 stimulate tyrosine phosphorylation of insulin receptor substrate 1 and 2 in T cells. J Biol Chem (1995) 270: 28527-30.
58. Yin T, Keller S, Quelle F et al, Interleukin-9 induces tyrosine phosphorylation of insulin receptor substrate-1 via JAK tyrosine kinases. J Biol Chem (1995) 270: 20497-502.
59. Sharfe N, Roifman CM, Differential association of phosphatidylinositol 3-kinase with insulin receptor substrate (IRS)-1 and IRS-2 in human thymocytes in response to IL-7. J Immunol (1997) 159: 1107-14.
60. Truitt KE, Mills GB, Truck CW et al, SH2-dependent association of phosphatidylinositol 3′-kinase 85-kDa regulatory subunit with the interleukin-2 receptor β chain. J Biol Chem (1994) 269: 5937-43.
61. Venkitaraman AR, Cowling RJ, Interleukin-7 induces the association of phosphatidylinositol 3-kinase with the a chain of the interleukin-7 receptor. Eur J Immunol (1994) 24: 2168-74.
62. Pfeffer L, Mullersman J, Pfeffer S et al, STAT3 as an adaptor to couple phosphatidylinositol 3-kinase to the IFNAR1 chain of the type I interferon receptor. Science (1997) 276: 1418-20.
63. Karnitz L, Sutor S, Abraham R, The src-family kinase, Fyn, regulates the activation of phosphatidylinositol 3-kinase in an interleukin 2-responsive T cell line. J Exp Med (1994) 179: 1799-808.
64. Sharfe N, Dadi H, Roifman C, JAK3 protein tyrosine kinase mediates interleukin-7-induced activation of phosphatidylinositol-3′ kinase. Blood (1995) 86: 2077-85.
65. Imani F, Rager K, Catipovic B et al, Interleukin-4 (IL-4) induces phosphatidylinositol 3-kinase (p85) dephosphorylation. J Biol Chem (1997) 272: 7927-31.
66. Taichman R, Merida I, Torigoe T et al, Evidence that protein tyrosine kinase p56-lck regulates the activity of phosphatidylinositol-3′-kinase in interleukin-2-dependent T-cells. J Biol Chem (1993) 268: 20031-6.
67. Klarlund J, Guilherme A, Holik J et al, Signaling by phosphoinositide-3,4,5-trisphosphate through proteins containing pleckstrin and sec7 homology domains. Science (1997) 275: 1927-30.
68. Hemmings B, Akt signaling: linking membrane events to life and death decisions. Science (1997) 275: 628-30.
69. Alessi D, James S, Downes P et al, Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Ba. Curr Biol (1997) 7: 261-9.
70. Reif K, Burgering B, Cantrell D, Phosphatidylinositol 3-kinase links the interleukin-2 receptor to protein kinase B and p70 S6 kinase. J Biol Chem (1997) 272: 14426-33.
71. Ahmed N, Grimes H, Bellacosa A et al, Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase. Proc Natl Acad Sci USA (1997) 94: 3627-32.
72. Brunn G, Williams J, Sabers C et al, Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmaimin and Ly294002. EMBO J (1996) 15: 5256-67.
73. Myers M, Grasner T, Wang L et al, Insulin receptor substrate-1 mediates phosphatidylinositol 3′-kinase and p70S6K signaling during insulin-like growth factor-1 and interleukin-4 stimulation. J Biol Chem (1994) 269: 28783-9.
74. Chou M, Blenis J, The 70 kDa S6 kinase: regulation of a kinase with multiple roles in mitogenic signalling. Curr Opin Cell Biol (1995) 7: 806-14.
75. Feuerstein N, Huang D, Prystowsky M-B, Rapamycin selectively blocks interleukin-2-induced proliferating nuclear antigen gene expression in T lymphocytes. Evidence for inhibition of CREB/ATF binding activities. J Biol Chem (1995) 270: 9454-8.
76. Gomez J, Martinez de Aragon A, Pitton C et al, Zeta isoform of protein kinase C controls IL-7 mediated proliferation in a murine T cell line: evidence for an additional role of protein kinase C ε and β. Exp Cell Res (1995) 218: 105-13.
77. Gomez J, Garcia A, R.-Borlado L et al, IL-2 signaling controls actin organization through Rho-like protein family, phosphatidylinositol 3-kinase, and protein kinase C-C. J Immunol (1997) 158: 1516-22.
78. Friedmann M, Aligone T-S, Russell S et al, Different interleukin 2 receptor β-chain tyrosines couple to at least two signaling pathways and synergistically mediate interleukin 2-induced proliferation. Proc Natl Acad Sci USA (1996) 93: 2077-82.
79. Karnitz L, Burns L, Sutor S et al, Interleukin-2 triggers a novel phosphatidylinositol 3-kinase-dependent AtEK activation pathway. Mol Cell Biol (1995) 15: 3049-57.
80. Hu Q, Klippel A, Muslin A et al, Ras-dependent induction of cellular responses by constitutively active phosphatidylinasitol-3 kinase. Science (1995) 268: 100-2.
81. Berra E, Diaz-Meco MT, Lozano J et al, Evidence for a role of MEK and MAPK during signal transduction by protein kinase C ζ. EMRO J (1995) 14: 6157-63.
82. Wery S, Letourneur M, Bertoglio J et al, Interleukin-4 induces activation of mitogen-activated protein kinase and phosphorylation of SHC in human keratinocytes. J Biol Chem (1996) 271: 8529-32.
83. Wang LM, Keegan A, Paul W et al, IL-4 activates a distinct signal transduction cascade from IL-3 in factor-dependent myeloid cells. EMBO J (1992) 11: 4899-908.
84. Miyazawa K, Hendrie P, Kim Y-J et al, Recombinant human interleukin-9 induces protein tyrosine phosphorylation and synergizes with steel factor to stimulate proliferation of the human factor-dependent cell line, MO7e. Blood (1992) 80: 1685-92.
85. Crawley J, Rawlinson L, Lali F et al, X cell proliferation in response to interleukins 2 and 7 requires p38MAP kinase activation. J Biol Chem (1997) 272: 15023-7.
86. Robinson M, Cobb M, Mitogen-activated protein kinase pathways. Curr Opin Cell Biol (1997) 9: 180-6.
87. Darnell J, STATs and gene regulation. Science (1997) 277: 1630-5.
88. Hou J, Schindler U, Henzel W et al, Identification and purification of human Stat proteins activated in response to interleukin-2. Immunity (1995) 2: 321-9.
89. Lin J-X, Migone T-S, Tsang M et al, The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, EL-13, and IL-15. Immunity (1995) 2: 331-9.
90. Fujii H, Nakagawa Y, Schindler U et al, Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor β chain but is not essential for the proliferative signal Transmission. Proc Nad Acad Sci USA (1995) 92: 5482-6.
91. Nielsen M, Svejgaard A, Skov S et al, Interleukin-2 induces tyrosine phosphorylation and nuclear translocation of STAT3 in human T lymphocytes. Eur J Immunol (1994) 24: 3082-6.
92. Stahl N, Farruggella T, Boulton T et al, Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science (1995) 267: 1349-53
93. Yin T, Lik-Shing Tsang M, Yang Y-C, JAK1 kinase forms complexes with interleukin-4 receptor and 4PS/Insulin receptor substrate-1-like protein and is activated by interleukin-4 and interleukin-9 in T lymphocytes. J Biol Chem (1994) 269: 26614-17.
94. Hou J, Schindler U, Henzel W et al, An interleukin-4-induced transcription factor: IL-4 Stat. Science (1994) 265: 1701-6.
95. Shimoda K, van Deursen J, Sangster M et al, Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene Nature (1996) 380: 630-3.
96. Takeda K, Tanaka T, Shi W et al, Essential role of Stat6 in IL-4 signalling. Nature (1996) 380: 627-30.
97. Kaplan M, Schindler U, Smiley S et al, Stat6 is required for mediating responses to IL-4 and for the development of TH2 cells. Cell (1996) 4: 313-19.
98. Ryan J, McReynolds L, Keegan A et al, Growth and gene expression are predominantly controlled by distinct regions of the human IL-4 receptor. Immunity (1996) 4: 123-32.
99. Wen Z, Zhong Z, Darnell J, Maximal activation of transcription by STAT1 and STAT3 requires both tyrosine and serine phosphorylation. Cell (1995) 82: 241-50.
100. Zhang X, Blenis J, Li HC et al, Requirement of serine phosphorylation for formation of STAT-promoter complexes Science (1995) 267: 1990-4.
101. Beadling C, Ng J, Babbage J et al, Interleukin-2 activation of STAT5 requires the convergent action of tyrosine kinases and a serine, threonine kinase pathway distinct from the Raf1/ERK2 MAP kinase pathway. EMBO J (1996) 15: 1902-13.
102. Gotoh A, Takahira H, Mantel C et al, Steel factor induces serine phosphorylation of STAT3 in human growth factor-dependent myeloid cell lines. Blood (1996) 88: 138-45.
103. Ng J, Cantrell D, STAT3 is a senne kinase target in T lymphocytes. J Biol Chem (1997) 272: 24542-9.
104. Ascherman D, Migone T-S, Friedmann M et al, Interleukin-2 (IL-2)-mediated induction of the IL-2 receptor a chain gene. J Biol Chem (1997) 272: 8704-9.
105. John S, Robbins C, Leonard W, An IL-2 response element in the human IL-2 receptor a chain promoter is a composite element that binds STAT5, Elf-1, HMG-I(Y) and a GATA family protein. EMBO J (1996) 15: 5627-35.
106. Klingmüller U, Lorenz U, Cantley L et al, Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell (1995) 80: 729-38.
107. Matsumoto A, Masuhara M, Mitsui K et al, CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation. Blood (1997) 89: 3148-54.
108. Starr R, Willson T, Viney E et al, A family of cytokine-inducible inhibitors of signalling. Nature (1997) 387: 917-21.
109. Naka T, N arazaki M, Hirata M et al, Structure and function of a new STAT-induced STAT inhibitor. Nature (1997) 387: 924-9.
110. Endo T, Masuhara M, Yokouchi M et al, A new protein containing an SH2 domain that inhibits JAK kinases. Nature (1997) 387: 921-4.
111. Mui A, Wakao H, Kinoshita T et al, Suppression of interleukin-3-induced gene expression by a C-terminal truncated Stat5: role of STAT5 in proliferation. EMBO J (1996) 15: 2425-33.
112. Buckley AR, Buckley D, Leff M et al, Rapid induction of pim-1 expression by prolactin and interleukin-2 in rat Nb2 lymphoma cells. Endocrinology (1995) 136: 5252-9.
113. Lang RA, Metcalf D, Goug NM et al, Expression of a hematopoietic growth factor cDNA in a factor-dependent cell line results in autonomous growth and tumorigenicity. Cell (1985) 43: 531-40.
114. Shibuya H, Yoneyama M, Ninomiya-Tsuji J et al, IL-2 and EGF receptors stimulate the hematopoietic cell cycle via different signaling pathways: demonstration of a novel role for c-myc. Cell (1992) 70: 57-67.
115. Feurestein N, Huang D, Prystowsky M, Rapamycin selectively blocks interleukin-2-induced proliferating cell nuclear antigen gene expression in T lymphocytes. Evidence for inhibition of CREB/ATF binding activities. J Biol Chem (1995) 270: 9454-8.
116. Shibuya H, Kohu K, Yamada K et al, Functional dissection of p561ck, a protein tyrosine kinase which mediates interleukin-2-induced activation of the c-fos gene. Mol Cell Biol (1994) 14: 5812-19.
117. Wang L, Myers M, Sun X et al, IRS-1: essential for insulin- and IL-4-stimulated mitogenesis in hematopoietic cells. Science (1993) 261: 1591-4.
118. Masmyth K, Viewpoint. pulling the cell cycle in order. Science (1996) 274: 1643-5.
119. Yang E, Korsmeyer S, Molecular thanatopsis: a discourse on the BCL2 family and cell death Blood (1996) 88: 386-401.
120. Renauld J-C, Vink A, Louahed J et al, IL-9 is a major antiapoptotic factor for thymic lymphomas. Blood (1995) 85: 1300-5.
121. Maraskovsky E, O'Reilly L, Teepe M et al, Bcl-2 can rescue T lymphocyte development in interleukin-7 receptor-deficient mice but not in mutant rag-1-/- mice Cell (1997) 89: 1011-19.
122. Kondo M, Akashi K, Domen J et al, Bcl-2 rescues T lymphopoiesis, but not B or NK cell development, in common gamma chain-deficient mice. Immunity (1997) 7: 155-62.
123. Akashi K, Kondo M, von Freeden-Jeffry U et al, Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell (1997) 89: 1033-41.
124. Louahed J, Renauld J-C, Demoulin J-B et al, Differential activity of dexamethasone on IL-2-, IL-4-, or IL-9-induced proliferation of murine factor-dependent T cell lines. J Immunol (1996) 156: 3704-10.
125. Franke T, Kaplan D, Cantley L, P13K: downstream AKTion blocks apoptosis. Cell (1997) 88: 435-7.
126. del Peso L, Gonzalez-Garcia M, Page C et al, Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science (1997) 278: 687-9.
127. Zha J, Harada H, Yang E et al, Senne phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not Bcl-XL. Cell (1996) 87: 619-28.
128. Baeuerle P, Baltimore D, NF-κB: ten years after. Cell (1996) 87: 13-20.
129. Kubo M, Ransom J, Webb D et al, T-cell subset-specific expression of the IL-4 gene is regulated by a silencer element and STAT6. EMBO J (1997) 16: 4007-20.
130. Demoulin J-B, Renauld J-C, Interleukin-9 and its receptor: an overview of structure and function. Int Rev Immunol (1998) 16: 345-64.
131. Louahed J, Kermouni A, Van Snick J et al, IL-9 induces expression of granzymes and high affinity IgE receptor in murine T helper clones. J Immunol (1995) 154: 5061-70.
132. Thomis D, Berg L, The role of JAK3 in lymphoid development, activation, and signaling. Curr Biol (1997) 9: 541-7.
133. Nosaka T, van Deursen J, Tripp R et al. Defective lymphoid development in mice lacking Jak3. Science (1995) 270: 800-2.